Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
Biotranex was acquired by Frontage Laboratories
MedGenome raised $55MM from Investors
Perspectum closed $36MM financing round, Co-led by Blue Venture Fund and HealthQuest